Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-01-21 1:37 pm Sale | 13G | SYNTHETIC BIOLOGICS INC NE SYN | SABBY MANAGEMENT LLC | 838,641 11% | -278,818 (-24.95%) | View |
2020-01-21 1:18 pm Sale | 13G | MONAKER GROUP INC MKGI | SABBY MANAGEMENT LLC | 315,400 11% | -195,026 (-38.21%) | View |
2020-01-21 1:03 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | SABBY MANAGEMENT LLC | 78,605 11% | 78,605 (New Position) | View |
2020-01-21 12:36 pm Purchase | 13G | INSPYR THERAPEUTICS INC PA NSPX | SABBY MANAGEMENT LLC | 1,137,260 11% | 1,137,260 (New Position) | View |
2020-01-21 12:17 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | SABBY MANAGEMENT LLC | 568,845 11% | 568,845 (New Position) | View |
2020-01-21 11:59 am Purchase | 13G | JAGUAR HEALTH INC PAR$ JAGX | SABBY MANAGEMENT LLC | 400,000 11% | 400,000 (New Position) | View |
2020-01-21 11:30 am Purchase | 13G | SENECA BIOPHARMA INC SNCA | SABBY MANAGEMENT LLC | 381,487 11% | 381,487 (New Position) | View |
2020-01-14 5:42 pm Sale | 13G | GENPREX INC GNPX | SABBY MANAGEMENT LLC | 948,890 11% | -635,117 (-40.10%) | View |
2020-01-14 5:28 pm Sale | 13G | YIELD10 BIOSCIENCE INC YTEN | SABBY MANAGEMENT LLC | 1,247,451 11% | -1,027,549 (-45.17%) | View |
2020-01-14 5:16 pm Sale | 13G | LIPOCINE INC LPCN | SABBY MANAGEMENT LLC | 1,770,341 11% | -1,329,659 (-42.89%) | View |
2020-01-14 5:04 pm Sale | 13G | APPLIED DNA SCIENCES INC P APDN | SABBY MANAGEMENT LLC | 173,921 11% | -76,079 (-30.43%) | View |
2020-01-14 4:53 pm Sale | 13G | TOP SHIPS INC SHS TOPS | SABBY MANAGEMENT LLC | 799,212 11% | -50,788 (-5.98%) | View |
2020-01-13 4:49 pm Sale | 13G | GUARDION HEALTH SCIENCES INC C GHSI | SABBY MANAGEMENT LLC | 3,741,630 11% | -3,458,370 (-48.03%) | View |
2020-01-13 4:32 pm Purchase | 13G | BENITEC BIOPHARMA LTD SPONSORE BNTC | SABBY MANAGEMENT LLC | 23,657,000 11% | 23,657,000 (New Position) | View |
2020-01-13 4:06 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | SABBY MANAGEMENT LLC | 8,741,243 11% | 8,458,099 (+2987.21%) | View |
2020-01-13 3:29 pm Purchase | 13G | XENETIC BIOSCIENCES INC PA XBIO | SABBY MANAGEMENT LLC | 287,182 11% | 33,822 (+13.35%) | View |
2020-01-13 3:14 pm Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | SABBY MANAGEMENT LLC | 3,322,282 11% | 1,749,699 (+111.26%) | View |
2020-01-09 4:48 pm Purchase | 13G | RESHAPE LIFESCIENCES INC C RSLS | SABBY MANAGEMENT LLC | 570,418 11% | 13,647 (+2.45%) | View |
2020-01-09 4:29 pm Sale | 13G | ECOARK HLDGS INC ZEST | SABBY MANAGEMENT LLC | 3,431,702 11% | -1,126,638 (-24.72%) | View |
2020-01-09 4:11 pm Sale | 13G | AMPIO PHARMACEUTICALS INC AMPE | SABBY MANAGEMENT LLC | 0 0% | -8,750,000 (Position Closed) | View |